Press Releases Press Releases Year None202020192018 Date Title October 26, 2020 InVivo Therapeutics Announces Closing of $15.0 Million Public Offering October 22, 2020 InVivo Therapeutics Announces Pricing of $15.0 Million Public Offering September 11, 2020 InVivo Therapeutics Announces Presentation at the Upcoming H.C Wainwright Virtual Global Investment Conference April 17, 2020 InVivo Therapeutics Announces Closing of $3.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules April 15, 2020 InVivo Therapeutics Announces $3.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules March 11, 2020 InVivo Therapeutics Announces Closing of $7.0 Million Public Offering March 6, 2020 InVivo Therapeutics Announces Pricing of $7.0 Million Public Offering February 3, 2020 InVivo Therapeutics Announces Reverse Stock Split Invivo - Investor Tools Print Page Email Alerts RSS Feeds Contact IR
Press Releases Year None202020192018 Date Title October 26, 2020 InVivo Therapeutics Announces Closing of $15.0 Million Public Offering October 22, 2020 InVivo Therapeutics Announces Pricing of $15.0 Million Public Offering September 11, 2020 InVivo Therapeutics Announces Presentation at the Upcoming H.C Wainwright Virtual Global Investment Conference April 17, 2020 InVivo Therapeutics Announces Closing of $3.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules April 15, 2020 InVivo Therapeutics Announces $3.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules March 11, 2020 InVivo Therapeutics Announces Closing of $7.0 Million Public Offering March 6, 2020 InVivo Therapeutics Announces Pricing of $7.0 Million Public Offering February 3, 2020 InVivo Therapeutics Announces Reverse Stock Split
